Health Affairs

• 

  Publication Venue For

  • ACO Serious Illness Care: Survey And Case Studies Depict Current Challenges And Future Opportunities..  38:1011-1020. 2019
  • Why Do Accountable Care Organizations Leave The Medicare Shared Savings Program?.  38:794-803. 2019
  • Physicians Are People, TooAlso Human: The Inner Lives Of Doctors By Caroline Elton New York (NY): Basic Books, 2018 336 pp., $30.00.  37:1337-1338. 2018
  • Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study..  37:765-772. 2018
  • Accountable Care Reforms Improve Women's And Children's Health In Nepal..  36:1965-1972. 2017
  • Global Lessons In Frugal Innovation To Improve Health Care Delivery In The United States..  36:1912-1919. 2017
  • Improving Care And Lowering Costs: Evidence And Lessons From A Global Analysis Of Accountable Care Reforms..  36:1920-1927. 2017
  • A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne Diseases..  36:1461-1468. 2017
  • A Positive Association Between Hospice Profit Margin And The Rate At Which Patients Are Discharged Before Death..  36:1291-1298. 2017
  • Bridging The Death GapThe Death Gap: How Inequality Kills By Ansell David A. Chicago (IL) : University of Chicago Press , 2017 240 pp., $26.00.  36:1140-1140. 2017
  • Medical Marijuana Laws May Be Associated With A Decline In The Number Of Prescriptions For Medicaid Enrollees..  36:945-951. 2017
  • Strategies For Assessing Delivery System Innovations..  36:408-416. 2017
  • Effect Of A Large-Scale Social Franchising And Telemedicine Program On Childhood Diarrhea And Pneumonia Outcomes In India..  35:1800-1809. 2016
  • Medical Marijuana Laws: The Authors Reply..  35:1937. 2016
  • Quality Of Health Care In India: Challenges, Priorities, And The Road Ahead..  35:1753-1758. 2016
  • Trends In State-Level Child Mortality, Maternal Mortality, And Fertility Rates In India..  35:1759-1763. 2016
  • Sight-Threatening Ocular Diseases Remain Underdiagnosed Among Children Of Less Affluent Families..  35:1359-1366. 2016
  • Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D..  35:1230-1236. 2016
  • The Commercial Market For Priority Review Vouchers..  35:776-783. 2016
  • Study Of Physician And Patient Communication Identifies Missed Opportunities To Help Reduce Patients' Out-Of-Pocket Spending..  35:654-661. 2016
  • Yelp Reviews Of Hospital Care Can Supplement And Inform Traditional Surveys Of The Patient Experience Of Care..  35:697-705. 2016
  • No Shot: US Vaccine Prices And Shortages..  35:235-241. 2016
  • Consumption Of Specific Foods And Beverages And Excess Weight Gain Among Children And Adolescents..  34:1940-1948. 2015
  • Guiding Principles And A Decision-Making Framework For Stakeholders Pursuing Healthy Food Environments..  34:1972-1978. 2015
  • The Complex Relationship Between Diet And Health..  34:1813-1820. 2015
  • Innovations In Diabetes Care Around the World: Case Studies Of Care Transformation Through Accountable Care Reforms..  34:1489-1497. 2015
  • Some state vaccination laws contribute to greater exemption rates and disease outbreaks in the United States..  34:1383-1390. 2015
  • Wide variation in payments for Medicare beneficiary oncology services suggests room for practice-level improvement..  34:601-608. 2015
  • Creating value in health by understanding and overcoming resistance to de-innovation..  34:239-244. 2015
  • Improving pharmaceutical innovation by building a more comprehensive database on drug development and use..  34:319-327. 2015
  • Repairing the broken market for antibiotic innovation..  34:277-285. 2015
  • The roles of patents and research and development incentives in biopharmaceutical innovation..  34:302-310. 2015
  • Cost-effectiveness: the authors reply..  34:188. 2015
  • An economic framework for preventive care advice..  33:2034-2040. 2014
  • The impact of specialty pharmaceuticals as drivers of health care costs..  33:1714-1720. 2014
  • Assessing the value of patient-generated data to comparative effectiveness research..  33:1220-1228. 2014
  • Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future..  33:1048-1057. 2014
  • Survey finds few orthopedic surgeons know the costs of the devices they implant..  33:103-109. 2014
  • Evolving Reimbursement And Pricing Policies For Devices In Europe And The United States Should Encourage Greater Value.  32:788-796. 2013
  • Mortality Under Age 50 Accounts For Much Of The Fact That US Life Expectancy Lags That Of Other High-Income Countries.  32:459-467. 2013
  • In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival..  31:709-717. 2012
  • Inviting consumers to downsize fast-food portions significantly reduces calorie consumption..  31:399-407. 2012
  • Nurses for patient-centered medical homes.  31:2593-. 2012
  • Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act..  30:2157-2166. 2011
  • Societal Impact Of Extending Market Exclusivity For Conventional Drugs.  30:798-798. 2011
  • The Benefits Of Health Information Technology: A Review Of The Recent Literature Shows Predominantly Positive Results.  30:464-471. 2011
  • Controversy undermines support for state mandates on the human papillomavirus vaccine..  29:2041-2046. 2010
  • Personal responsibility and obesity: a constructive approach to a controversial issue..  29:379-387. 2010
  • Predicting support for restricting food marketing to youth..  29:419-424. 2010
  • Cancer therapy costs influence treatment: a national survey of oncologists..  29:196-202. 2010
  • How four once common diseases were eliminated from the American South..  28:1734-1744. 2009
  • Annual medical spending attributable to obesity: payer-and service-specific estimates..  28:w822-w831. 2009
  • Colorectal cancer screening: prevalence among low-income groups with health insurance..  28:169-177. 2009
  • Fueling innovation in medical devices (and beyond): venture capital in health care..  28:w68-w75. 2009
  • Availability and prices of foods across stores and neighborhoods: the case of New Haven, Connecticut..  27:1381-1388. 2008
  • Would greater transparency and uniformity of health care prices benefit poor patients?.  26:1384-1391. 2007
  • Consider it done? The likely efficacy of mandates for health insurance.  26:1612-1621. 2007
  • How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior..  25:1371-1377. 2006
  • Developing drugs for developing countries..  25:313-324. 2006
  • The quantity and quality of worldwide new drug introductions, 1982-2003..  25:452-460. 2006
  • Postapproval drug safety: The authors respond.  25:1187-1188. 2006
  • Postapproval drug safety: The authors respond [8].  25:1187-1188. 2006
  • Functional gaps in attaining a national health information network..  24:1281-1289. 2005
  • The making and adoption of health data standards..  24:1205-1213. 2005
  • What about physician assistants?.  24:886-887. 2005
  • Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior..  24:483-490. 2005
  • The impact of Blue Cross conversions on health spending and the uninsured..  24:473-482. 2005
  • Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator..  24:42-51. 2005
  • States' allocations of funds from the tobacco master settlement agreement..  24:220-227. 2005
  • Securitization of tobacco settlement payments to reduce states' conflict of interest..  23:188-193. 2004
  • Overcoming barriers to adopting and implementing computerized physician order entry systems in U.S. hospitals..  23:184-190. 2004
  • The general agreement on trade in services: implications for health policymakers..  23:137-145. 2004
  • Does competition for transplantable hearts encourage 'gaming' of the waiting list?.  23:191-198. 2004
  • Better health, lower spending..  23:273-274. 2004
  • Defining the balance of risk and benefit in the era of genomics and proteomics..  23:77-87. 2004
  • The role of standards in electronic prescribing..  Suppl Web Exclusives:W4-325-7. 2004
  • The role of standards in electronic prescribing..  Suppl Web Exclusives. 2004
  • Mandated treatment in the community for people with mental disorders..  22:28-38. 2003
  • National medical spending attributable to overweight and obesity: how much, and who's paying?.  Suppl Web Exclusives:W3-219-26. 2003
  • Pharmacogenetic challenges for the health care system..  21:155-167. 2002
  • How Disclosing HMO Physician Incentives Affects Trust.  21:197-206. 2002
  • The economics of alcohol abuse and alcohol-control policies..  21:120-133. 2002
  • Gauging supply and demand: the challenging quest to predict the future physician workforce..  21:167-168. 2002
  • Providing care at the end of life: do Medicare rules impede good care?.  20:204-211. 2001
  • Does economic theory justify changing policy that works?.  20:153-155. 2001
  • Does economic theory justify changing policy that works?.  20:153-155. 2001
  • Pennsylvania's voluntary benefits program: evaluating an innovative proposal for increasing organ donation..  19:206-211. 2000
  • Managed behavioral health care: a Medicaid carve-out for youth..  18:214-225. 1999
  • Children's mental health service use across service sectors..  14:147-159. 1995
  • Nursing home reform and the mentally ill..  9:47-60. 1990
  • The cultural dimensions of alcohol policy worldwide..  8:48-62. 1989
  • Shifting Medicare patients out of the hospital..  7:52-64. 1988
  • Is state rate setting the best path to controlling costs?.  6:170-172. 1987
  • Projecting the impact of AIDS on hospitals..  6:19-31. 1987
  • Uncovering the high costs of teaching hospitals..  5:68-85. 1986
  • Rising rates of surgery among the elderly..  4:108-119. 1985
  • Investor-owned and not-for-profit hospitals: Addressing some issues.  2:25-37. 1983
  • State rate setting: an analysis of some unresolved issues..  2:36-47. 1983